Comparison of adaptive pacing therapy, cognitive behaviour therapy, graded exercise therapy, and specialist medical care for chronic fatigue syndrome (PACE): a randomised trial

P D White, K A Goldsmith, A L Johnson, L Potts, R Walwyn, J C DeCesare, H L Baber, M Burgess, L V Clark, D L Cox, J Bavinton, B J Angus, G Murphy, M Murphy, H O'Dowd, D Wilks, P McCrone, T Chalder, M Sharpe, PACE trial management group, Janet Darbyshire, Jenny Butler, Patrick Doherty, Stella Law, M Llewelyn, Tom Sensky, Mansel Aylward, Peter Spencer, Chris Clark, Stephen Stansfeld, Alison Wearden, Paul Dieppe, Astrid Fletcher, Charlotte Feinmann, Hiroko Akagi, Alastair Miller, Gavin Spickett, Barbara Bowman, Deborah Fleetwood, P D White, K A Goldsmith, A L Johnson, L Potts, R Walwyn, J C DeCesare, H L Baber, M Burgess, L V Clark, D L Cox, J Bavinton, B J Angus, G Murphy, M Murphy, H O'Dowd, D Wilks, P McCrone, T Chalder, M Sharpe, PACE trial management group, Janet Darbyshire, Jenny Butler, Patrick Doherty, Stella Law, M Llewelyn, Tom Sensky, Mansel Aylward, Peter Spencer, Chris Clark, Stephen Stansfeld, Alison Wearden, Paul Dieppe, Astrid Fletcher, Charlotte Feinmann, Hiroko Akagi, Alastair Miller, Gavin Spickett, Barbara Bowman, Deborah Fleetwood

Abstract

Background: Trial findings show cognitive behaviour therapy (CBT) and graded exercise therapy (GET) can be effective treatments for chronic fatigue syndrome, but patients' organisations have reported that these treatments can be harmful and favour pacing and specialist health care. We aimed to assess effectiveness and safety of all four treatments.

Methods: In our parallel-group randomised trial, patients meeting Oxford criteria for chronic fatigue syndrome were recruited from six secondary-care clinics in the UK and randomly allocated by computer-generated sequence to receive specialist medical care (SMC) alone or with adaptive pacing therapy (APT), CBT, or GET. Primary outcomes were fatigue (measured by Chalder fatigue questionnaire score) and physical function (measured by short form-36 subscale score) up to 52 weeks after randomisation, and safety was assessed primarily by recording all serious adverse events, including serious adverse reactions to trial treatments. Primary outcomes were rated by participants, who were necessarily unmasked to treatment assignment; the statistician was masked to treatment assignment for the analysis of primary outcomes. We used longitudinal regression models to compare SMC alone with other treatments, APT with CBT, and APT with GET. The final analysis included all participants for whom we had data for primary outcomes. This trial is registered at http://isrctn.org, number ISRCTN54285094.

Findings: We recruited 641 eligible patients, of whom 160 were assigned to the APT group, 161 to the CBT group, 160 to the GET group, and 160 to the SMC-alone group. Compared with SMC alone, mean fatigue scores at 52 weeks were 3·4 (95% CI 1·8 to 5·0) points lower for CBT (p = 0·0001) and 3·2 (1·7 to 4·8) points lower for GET (p = 0·0003), but did not differ for APT (0·7 [-0·9 to 2·3] points lower; p = 0·38). Compared with SMC alone, mean physical function scores were 7·1 (2·0 to 12·1) points higher for CBT (p = 0·0068) and 9·4 (4·4 to 14·4) points higher for GET (p = 0·0005), but did not differ for APT (3·4 [-1·6 to 8·4] points lower; p=0·18). Compared with APT, CBT and GET were associated with less fatigue (CBT p = 0·0027; GET p = 0·0059) and better physical function (CBT p=0·0002; GET p<0·0001). Subgroup analysis of 427 participants meeting international criteria for chronic fatigue syndrome and 329 participants meeting London criteria for myalgic encephalomyelitis yielded equivalent results. Serious adverse reactions were recorded in two (1%) of 159 participants in the APT group, three (2%) of 161 in the CBT group, two (1%) of 160 in the GET group, and two (1%) of 160 in the SMC-alone group.

Interpretation: CBT and GET can safely be added to SMC to moderately improve outcomes for chronic fatigue syndrome, but APT is not an effective addition.

Funding: UK Medical Research Council, Department of Health for England, Scottish Chief Scientist Office, Department for Work and Pensions.

Copyright © 2011 Elsevier Ltd. All rights reserved.

Figures

Figure 1
Figure 1
CONSORT trial profile CFS=chronic fatigue syndrome. APT=adaptive pacing therapy. CBT=cognitive behaviour therapy. GET=graded exercise therapy. SMC=specialist medical care alone. The numbers of participants per centre ranged from 63 to 135.
Figure 2
Figure 2
Physical function subscale and fatigue questionnaire scores by treatment group Data are unadjusted means (95% CI). pinteraction is the p-value of the interaction between treatment and criteria or disorder from the adjusted model. CFS=chronic fatigue syndrome. ME=myalgic encephalomyelitis. (A–D) Lowest fatigue score is best. (E–H) Highest physical function score is best.
Figure 3
Figure 3
Primary outcome treatment differences for fatigue (A) and physical function (B) at 52 weeks (A) Negative values for fatigue favour the first treatment group in each pair of comparisons. (B) Positive values for physical function favour the first treatment group in each pair of comparisons. APT=adaptive pacing therapy. SMC=specialist medical care. CBT=cognitive behaviour therapy. GET=graded exercise therapy.

References

    1. Prins JB, van der Meer JW, Bleijenberg G. Chronic fatigue syndrome. Lancet. 2006;367:346–355.
    1. National Institute for Health and Clinical Excellence Clinical guideline CG53. Chronic fatigue syndrome/myalgic encephalomyelitis (or encephalopathy): diagnosis and management. (accessed Nov 6, 2010).
    1. Cairns R, Hotopf M. A systematic review describing the prognosis of chronic fatigue syndrome. Occup Med. 2005;55:20–31.
    1. Edmonds M, McGuire H, Price JR. Exercise therapy for chronic fatigue syndrome. Cochrane Database Syst Rev. 2004;3 CD003200.
    1. Bagnall A-M, Hempel S, Chambers D, Orton V, Forbes C. The treatment and management of chronic fatigue syndrome (CFS)/myalgic encephalomyelitis (ME) in adults and children: update of CRD Report 22. (accessed Nov 6, 2010).
    1. Malouff JM, Thorsteinsson EB, Rooke SE, Bhullar N, Schutte NS. Efficacy of cognitive behavioral therapy for chronic fatigue syndrome: a meta-analysis. Clin Psychol Rev. 2008;28:736–745.
    1. Price JR, Mitchell E, Tidy E, Hunot V. Cognitive behaviour therapy for chronic fatigue syndrome in adults. Cochrane Database Syst Rev. 2008;3 CD001027.
    1. Action for ME. ME 2008: what progress? Action for ME, 2008. (accessed Nov 6, 2010).
    1. ME Association Managing my ME. What people with ME/CFS and their carers want from the UK's health and social services. (accessed Nov 6, 2010).
    1. White PD, Sharpe MC, Chalder T, DeCesare JC, Walwyn R, on behalf of the PACE trial group Protocol for the PACE trial: a randomised controlled trial of adaptive pacing, cognitive behaviour therapy, and graded exercise, as supplements to standardised specialist medical care versus standardised specialist medical care alone for patients with the chronic fatigue syndrome/myalgic encephalomyelitis or encephalopathy. BioMed Cent Neurol. 2007;7:6.
    1. Sharpe MC, Archard LC, Banatvala JE. A report—chronic fatigue syndrome. J Roy Soc Med. 1991;84:118–121.
    1. Reeves WC, Lloyd A, Vernon SD. The international chronic fatigue syndrome study group identification of ambiguities in the 1994 chronic fatigue syndrome research case definition and recommendations for resolution. BMC Health Serv Res. 2003;3:2.
    1. The London criteria . Report on chronic fatigue syndrome (CFS), post viral fatigue syndrome (PVFS) and myalgic encephalomyelitis (ME) The National Task Force; Westcare, Bristol: 1994.
    1. First MB, Spitzer RL, Gibbon M, Williams JBW. Structured Clinical Interview for DSM-IV-TR axis I disorders, research version, patient edition with psychotic screen (SCID-I/P W/ PSY SCREEN) Biometrics Research, New York State Psychiatric Institute; New York: 2002.
    1. Chalder T, Berelowitz G, Hirsch S, Pawlikowska T, Wallace P, Wessely S. Development of a fatigue scale. J Psychosom Res. 1993;37:147–153.
    1. McHorney CA, Ware JE, Raczek AE. The MOS 36 item short form health survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247–263.
    1. Pesek JR, Jason LA, Taylor RR. An empirical investigation of the envelope theory. J Human Behav Soc Environ. 2000;3:59–77.
    1. Action for ME Pacing for people with ME. (accessed Nov 6, 2010).
    1. Sharpe M, Hawton K, Simkin S. Cognitive behaviour therapy for the chronic fatigue syndrome: a randomised controlled trial. BMJ. 1996;312:22–26.
    1. Deale A, Chalder T, Marks I, Wessely S. Cognitive behavior therapy for chronic fatigue syndrome: a randomized controlled trial. Am J Psychiatry. 1997;154:408–414.
    1. Prins JB, Bleijenberg G, Bazelmans E. Cognitive behaviour therapy for chronic fatigue syndrome: a multicentre randomised controlled trial. Lancet. 2001;357:841–847.
    1. Fulcher KY, White PD. Randomised controlled trial of graded exercise in patients with the chronic fatigue syndrome. BMJ. 1997;314:1647–1652.
    1. Moss-Morris R, Sharon C, Tobin R, Baldi JC. A randomized controlled graded exercise trial for chronic fatigue syndrome: outcomes and mechanisms of change. J Health Psychol. 2005;10:245–259.
    1. Cox DL, Araoz G. The experience of therapy supervision within a UK multi-centre randomized controlled trial. Learn Health Soc Care. 2009;8:301–314.
    1. Guy W. ECDEU assessment manual for psychopharmacology. National Institute of Mental Health; Rockville, MD: 1976. pp. 218–222.
    1. Mundt JC, Marks IM, Shear K, Griest JH. The work and social adjustment scale: a simple measure of impairment in functioning. Br J Psychiatry. 2002;180:461–464.
    1. Butland RJA, Pang J, Gross ER, Woodcock AA, Geddes DM. Two, six, and 12 minute walking test in respiratory disease. BMJ. 1982;284:1607–1608.
    1. Jenkins CD, Stanton B, Niemcryk S, Rose R. A scale for the estimation of sleep problems in clinical research. J Clin Epidemiol. 1988;41:313–321.
    1. Zigmond A, Snaith R. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983;87:361–370.
    1. Senn S, Julious S. Measurement in clinical trials: a neglected issue for statisticians? Stats Med. 2009;28:3189–3209.
    1. Guyatt GH, Osaba D, Wu AW. Methods to explain the clinical significance of health status measures. Mayo Clinic Proceedings. 2002;77:371–383.
    1. Cella M, Chalder T. Measuring fatigue in clinical and community settings. J Psychosom Res. 2010;69:17–22.
    1. Bowling A, Bond M, Jenkinson C, Lamping DL. Short form 36 (SF-36) health survey questionnaire: which normative data should be used? Comparisons between the norms provided by the Omnibus Survey in Britain, The Health Survey for England and the Oxford Healthy Life Survey. J Publ Health Med. 1999;21:255–270.
    1. Wearden AJ, Dowrick C, Chew-Graham C. Fatigue Intervention by Nurses Evaluation (FINE) trial writing group and the FINE trial group. Nurse led, home based self help treatment for patients in primary care with chronic fatigue syndrome: randomised controlled trial. BMJ. 2010;340:c1777.
    1. Jason LA, Torres-Harding S, Friedberg F. Non-pharmacologic interventions for CFS: a randomized trial. J Clin Psychol Med Settings. 2007;14:275–296.
    1. Wearden AJ, Morriss RK, Mullis R. Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome. Br J Psychiatry. 1998;172:485–490.
    1. Heins MJ, Knoop H, Prins JB, Stulemeijer M, van der Meer JWM, Bleijenberg G. Possible detrimental effects of cognitive behaviour therapy for chronic fatigue syndrome. Psychother Psychosom. 2010;79:249–256.

Source: PubMed

3
Suscribir